Anna Pannaccione Selected Research

Demyelinating Diseases (Demyelinating Disease)

1/2019

D-Aspartate treatment attenuates myelin damage and stimulates myelin repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anna Pannaccione Research Topics

Disease

7	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 08/2012
7	Brain Ischemia (Cerebral Ischemia) 01/2019 - 01/2008
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 11/2009
4	Infarction (Infarctions) 08/2015 - 02/2008
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 01/2020
3	Stroke (Strokes) 01/2019 - 01/2013
1	Dementia (Dementias) 12/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 12/2022
1	Neuroinflammatory Diseases 01/2022
1	Insulin Resistance 01/2022
1	Central Nervous System Diseases (CNS Diseases) 01/2021
1	Demyelinating Diseases (Demyelinating Disease) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Schizophrenia (Dementia Praecox) 01/2019
1	Seizures (Absence Seizure) 01/2019
1	Memory Disorders (Memory Loss) 01/2013
1	Hypoxia (Hypoxemia) 03/2009
1	Nervous System Diseases (Neurological Disorders) 04/2003

Drug/Important Bio-Agent (IBA)

5	Sodium-Calcium ExchangerIBA 03/2016 - 03/2009
4	CalciumIBA 01/2022 - 02/2013
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2019
3	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2013
3	Oxygen (Dioxygen)IBA 01/2019 - 02/2013
2	Peptides (Polypeptides)IBA 01/2022 - 08/2012
2	IonsIBA 01/2021 - 02/2013
2	SodiumIBA 01/2020 - 02/2013
2	Protein Isoforms (Isoforms)IBA 08/2015 - 01/2013
2	AntiportersIBA 01/2013 - 01/2013
2	sodium-calcium exchanger 1IBA 01/2013 - 11/2009
1	NeurotoxinsIBA 12/2022
1	beta-N-methylamino-L-alanine (beta-methylamino-L-alanine)IBA 12/2022
1	PhytochemicalsIBA 01/2022
1	Monoterpenes (Monoterpenoids)IBA 01/2022
1	PolyphenolsIBA 01/2022
1	Protective AgentsIBA 06/2021
1	Volatile Oils (Essential Oils)IBA 06/2021
1	AcidsIBA 01/2021
1	Sodium Channels (Sodium Channel)IBA 01/2021
1	Ion Channels (Ion Channel)IBA 01/2021
1	ORAI1 ProteinIBA 01/2019
1	Voltage-Gated Sodium ChannelsIBA 01/2019
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019
1	D-Aspartic Acid (D Aspartate)IBA 01/2019
1	Calbindin 2IBA 03/2016
1	Calcium-Binding ProteinsIBA 03/2016
1	Dihydrotachysterol (AT 10)IBA 08/2015
1	5- amino- N- butyl- 2- (4- ethoxyphenoxy)- benzamide hydrochlorideIBA 08/2015
1	RE1-silencing transcription factorIBA 02/2013
1	7- nitro- 5- phenyl- 1- (pyrrolidin- 1- ylmethyl)- 1H- benzo(e)(1,4)diazepin- 2(3H)- oneIBA 01/2013
1	Neuroprotective AgentsIBA 01/2013
1	EstersIBA 11/2009
1	Carisoprodol (Soma)FDA LinkGeneric 11/2009
1	Fura-2 (Fura 2)IBA 11/2009
1	NF-kappa B (NF-kB)IBA 03/2009
1	OligodeoxyribonucleotidesIBA 02/2008
1	Proteins (Proteins, Gene)FDA Link 01/2008
1	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2003

Therapy/Procedure

1	Therapeutics 07/2020